Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Accepts healthy volunteers Results available

To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older

ClinicalTrials.gov ID: NCT04754594

Public ClinicalTrials.gov record NCT04754594. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 2:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 2/3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A SARS-COV-2 RNA VACCINE CANDIDATE (BNT162b2) AGAINST COVID-19 IN HEALTHY PREGNANT WOMEN 18 YEARS OF AGE AND OLDER

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Results will be submitted, however please note that data are not yet available for all serology outcome measures. This will be a Phase 2/3, randomized, placebo-controlled, observer-blind study evaluating the safety, tolerability, and immunogenicity of 30 µg of BNT162b2 or placebo administered in 2 doses, 21 days apart, in approximately 350 healthy pregnant women 18 years of age or older vaccinated at 24 to 34 weeks' gestation. Participants will be randomized 1:1 to receive BNT162b2 or placebo (saline).

Study identification

NCT ID
NCT04754594
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
BioNTech SE
Industry
Enrollment
726 participants

Conditions and interventions

Interventions

Biological · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 16, 2021 (Actual)
Primary completion
Jul 15, 2022 (Actual)
Completion
Jul 15, 2022 (Actual)
Last update posted
Dec 6, 2024

2021 – 2022

United States locations

U.S. sites
56
U.S. states
12
U.S. cities
31
Facility City State ZIP Site status
Children's of Alabama Birmingham Alabama 35233 —
University of Alabama at Birmingham Women & Infant Center Birmingham Alabama 35233 —
University of Alabama at Birmingham/Center for Women's Reproductive Health Birmingham Alabama 35233 —
Velocity Clinical Research, Gulfport Mobile Alabama 36608 —
Arrowhead Hospital Glendale Arizona 85308 —
Abrazo West Campus Hospital Goodyear Arizona 85395 —
St. Joseph Hospital Phoenix Arizona 85013 —
MedPharmics, LLC Phoenix Arizona 85015 —
Matrix Clinical Research. Huntington Park California 90255 —
Matrix Clinical Research Huntington Park California 90255 —
Chemidox Clinical Trials Inc. Lancaster California 93534 —
East LA Doctors Hospital Los Angeles California 90023 —
Matrix Clinical Research Los Angeles California 90057 —
Axcess Medical Research Loxahatchee Groves Florida 33470 —
Idaho Falls Pediatrics Ammon Idaho 83406 —
Bingham Memorial Hospital Blackfoot Idaho 83221 —
Idaho Falls Pediatrics Idaho Falls Idaho 83402 —
Clinical Research Prime Idaho Falls Idaho 83404 —
Eastern Idaho Regional Medical Center Idaho Falls Idaho 83404 —
Mountain View Hospital Idaho Falls Idaho 83404 —
Covenant Healthcare Saginaw Michigan 48604 —
Saginaw Valley Medical Research Group, LLC Saginaw Michigan 48604 —
Community Hospital of Anaconda Anaconda Montana 59711 —
Boeson Research (BUT) Butte Montana 59701 —
SCL St. James Healthcare Hospital Butte Montana 59701 —
Marcus Daly Memorial Hospital Hamilton Montana 59840 —
Providence St. Patrick Hospital Missoula Montana 59802 —
The Birth Center Missoula Montana 59803 —
Boeson Research Missoula Montana 59804 —
Community Medical Center Missoula Montana 59804 —
Community Physicians Group-Maternal Fetal Medicine Missoula Montana 59804 —
St. Luke Community Healthcare Hospital Ronan Montana 59864 —
Meridian Clinical Research, LLC Hastings Nebraska 68901 —
Meridian Clinical Research, LLC Norfolk Nebraska 68701 —
Allegheny Health and Wellness Pavilion Erie Pennsylvania 16506 —
OBGYN Associates of Erie Erie Pennsylvania 16507 —
Central Erie Primary Care Erie Pennsylvania 16508 —
Liberty Family Practice Erie Pennsylvania 16508 —
Saint Vincent Hospital Erie Pennsylvania 16544 —
St. David's Medical Center Austin Texas 78705 —
Tekton Research, Inc. Austin Texas 78705 —
Tekton Research, Inc. Austin Texas 78745 —
Texas Health Harris Methodist Hospital Hurst-Euless-Bedford Bedford Texas 76022 —
Ventavia Research Group LLC Dallas Texas 75231 —
DHR Health Institute for Research and Development Edinburg Texas 78539 —
8th Avenue Obstetrics & Gynecology Fort Worth Texas 76104 —
Baylor Scott & White All Saints Medical Center Fort Worth Texas 76104 —
Ventavia Research Group, LLC Fort Worth Texas 76104 —
Dr. Ruben Aleman & Associates McAllen Texas 78504 —
Ventavia Research Group, LLC Plano Texas 75093 —
Ventavia Research Group, LLC Weatherford Texas 76086 —
Weatherford OBGYN Weatherford Texas 76086 —
University of Utah Hospital Salt Lake City Utah 84132 —
University of Utah Salt Lake City Utah 84132 —
The Group for Women- MAWC Norfolk Virginia 23502 —
Tidewater Physicians for Women- MAWC Norfolk Virginia 23502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04754594, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 6, 2024 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04754594 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →